IFIT2 and osteosarcoma: Increased IFIT2 levels activate the TNF/NF-κB pathway—a pivotal driver of osteosarcoma—resulting in enhanced cell proliferation, suppressed apoptosis, and heightened invasive and metastatic capacities [39].